background
recent
advanc
xenotransplant
produc
organ
pig
well
toler
primat
model
genet
chang
engin
delet
major
antigen
donor
anim
ensur
safeti
human
transplant
recipi
essenti
understand
spectrum
infecti
agent
donor
pig
potenti
transmit
immunocompromis
transplant
recipi
equal
import
develop
new
highli
sensit
diagnost
method
use
detect
agent
donor
anim
monitor
transplant
recipi
herein
report
develop
panel
quantit
polymeras
chain
reaction
qpcr
assay
infecti
agent
potenti
transmit
human
host
reproduc
sensit
specif
assay
evalu
found
exhibit
analyt
sensit
similar
quantit
assay
use
perform
viral
load
test
human
virus
clinic
laboratori
result
analyt
approach
use
detect
nucleic
acid
infecti
agent
present
specimen
sow
piglet
deriv
caesarean
section
commonli
detect
target
adult
anim
mycoplasma
speci
two
distinct
herpesvirus
porcin
lymphotroph
herpesviru
total
piglet
deriv
three
sow
infect
either
herpesvirus
yet
none
test
posit
virus
indic
vertic
transmiss
virus
ineffici
data
present
demonstr
procedur
place
highli
sensit
specif
detect
nucleic
acid
target
organ
panel
thu
ensur
safeti
organ
transplant
well
monitor
patient
potenti
receiv
coronavirus
herpesvirus
infecti
diseas
panel
viru
safeti
xenotransplant
continu
shortag
organ
transplant
limit
number
transplant
year
mani
patient
die
organ
becom
avail
transplant
porcin
organ
becom
increasingli
attract
approach
genom
edit
techniqu
succeed
reduc
reject
rate
transplant
organ
transmiss
infecti
diseas
transplant
alway
concern
allogen
transplant
associ
reactiv
opportunist
infect
recipi
also
infecti
agent
present
donor
tissu
transmit
immunosuppress
host
case
xenotransplant
transmiss
zoonot
infect
hepat
e
viru
hev
porcin
infecti
agent
might
gain
access
human
host
transplant
addit
concern
present
full
spectrum
infecti
agent
potenti
transmiss
human
host
might
produc
patholog
transplant
porcin
organ
complet
defin
improv
time
go
forward
ensur
safeti
organ
paramount
import
use
highli
sensit
techniqu
detect
potenti
pathogen
help
minim
advers
event
xenotransplant
highli
sensit
method
use
detect
human
virus
transplant
recipi
appli
detect
porcin
virus
pig
recent
review
notabl
exampl
includ
detect
porcin
cytomegaloviru
pcmv
hepat
e
viru
hev
use
quantit
polymeras
chain
reaction
qpcr
sensit
perform
analyt
method
appear
compar
use
clinic
set
detect
opportunist
infect
human
transplant
recipi
inde
assay
promis
character
porcin
sampl
much
rigor
level
use
qualifi
tissu
human
donor
studi
describ
part
larger
effort
gener
genet
engin
porcin
organ
use
clinic
trial
evalu
potenti
xenotransplant
specif
set
target
includ
virus
mycoplasma
speci
select
includ
agent
potenti
impact
health
graft
tissu
potenti
transmit
human
transplant
herein
describ
diagnost
approach
detect
broad
spectrum
infecti
agent
adapt
primer
probe
set
report
literatur
conform
common
amplif
protocol
common
instrument
new
test
regimen
util
detect
target
sow
piglet
deriv
cesarean
section
mani
agent
set
expect
present
distinct
tissu
blood
nasal
swab
stool
swab
evalu
enhanc
detect
data
confirm
presenc
virus
endem
pig
popul
unit
state
approach
use
help
establish
frequenc
mani
infect
herd
final
data
show
piglet
deriv
cesarean
section
infect
agent
detect
sow
deriv
consist
previou
report
herpesvirus
valid
infecti
diseas
test
assay
set
posit
control
plasmid
design
synthes
provid
target
sequenc
reaction
descript
sequenc
target
assay
shown
tabl
includ
sequenc
primer
probe
access
number
cognat
agent
genom
coordin
plasmid
contain
multipl
target
well
sequenc
herp
simplex
viru
hsv
facilit
absolut
quantif
plasmid
valid
assay
clinic
laboratori
establish
primer
method
plasmid
synthes
swine
influenza
ifa
reoviru
reoviru
rotaviru
rota
plasmid
dilut
yield
control
solut
low
copi
number
quantifi
clinic
laboratori
quantit
qpcr
assay
use
measur
viral
load
clinic
specimen
absolut
copi
number
target
dna
solut
adjust
copi
number
plasmid
equival
experiment
confirm
hsv
qpcr
assay
clinic
laboratori
final
control
solut
mix
equimolar
ratio
produc
control
solut
serv
quantit
control
target
describ
possibl
qpcr
assay
report
literatur
perform
report
other
requir
adapt
compat
common
test
platform
use
facilit
parallel
evalu
target
quantstudio
flex
instrument
target
sequenc
adapt
assay
design
within
amplifi
region
report
literatur
least
overlap
sequenc
identifi
refer
cite
tabl
primer
probe
use
studi
shown
tabl
togeth
access
number
nucleotid
sequenc
use
design
primer
genom
coordin
target
well
refer
form
basi
assay
primer
obtain
commerci
supplier
integr
dna
technolog
coralvil
ia
probe
obtain
nq
quantit
assay
na
applic
report
first
time
lower
limit
detect
llod
shown
copi
number
detect
frequenc
poisson
analysi
concentr
fewer
posit
specimen
detect
whichev
greater
supplier
fam
fluoresc
dye
intern
zen
iowa
black
quencher
analyt
approach
enabl
parallel
test
target
time
advantag
flexibl
target
detect
addit
primer
probe
set
calcul
copi
number
use
standard
formula
log
addit
control
includ
intern
control
viru
influenza
b
viru
ifb
spike
specimen
pig
ensur
interf
substanc
sampl
revers
transcript
detect
reaction
perform
accord
specif
intern
control
qpcr
use
detect
control
describ
previous
use
detect
viru
human
clinic
trial
control
qpcr
porcin
cyclophilin
sequenc
genom
dna
also
includ
assay
ensur
integr
sampl
preanalyt
control
experi
perform
method
prescrib
standard
oper
procedur
laboratori
ensur
integr
analyt
method
qualiti
assur
measur
confirm
data
experi
valid
lower
limit
detect
studi
dilut
control
dna
prepar
yield
concentr
rang
copi
per
reaction
copi
number
dilut
control
determin
separ
assay
probit
analysi
use
calcul
lowest
copi
number
could
detect
frequenc
function
varianc
experiment
valu
data
log
copi
number
control
plasmid
log
copi
number
experiment
determin
data
enter
graphpad
prism
la
jolla
ca
bestfit
equat
slope
xand
yintercept
r
coeffici
standard
deviat
residu
syx
calcul
probit
analysi
data
perform
excel
evalu
varianc
assay
seri
differ
control
concentr
use
calcul
lower
limit
detect
llod
defin
copi
number
could
detect
assay
reaction
qualit
assay
llod
defin
lowest
copi
number
posit
signal
obtain
separ
determin
second
set
studi
separ
dilut
seri
copi
use
confirm
result
probit
analysi
lower
limit
detect
defin
lowest
concentr
concentr
posit
piglet
obtain
somat
cell
nuclear
transfer
scnt
produc
research
purpos
piglet
femal
genet
background
landrac
x
yorkshir
piglet
deriv
via
caesarian
section
briefli
inch
incis
made
longitudin
ventromedi
line
last
teat
umbilicu
abdomin
caviti
access
uteru
expos
uterotomi
incis
made
along
uterin
horn
remov
fetus
altern
litter
deriv
hysterectomi
entir
uteru
move
tabl
piglet
harvest
everi
piglet
extract
hand
assist
umbil
cord
clamp
dip
povidoneiodin
sign
abnorm
record
newborn
move
clean
room
dedic
piglet
piglet
pen
equip
supplement
lamp
heat
neonat
piglet
receiv
mycoplasma
circoviru
vaccin
week
old
piglet
sampl
taken
birth
euthanasia
anim
day
age
specimen
evalu
studi
typic
includ
blood
stool
swab
nasal
swab
vari
depend
harvest
swab
contain
nasal
stool
specimen
ad
standard
viral
transport
media
vtm
supplement
nystatin
gentamycin
mix
ratio
rnalat
invitrogen
carlsbad
ca
blood
specimen
materi
collect
paxgen
blood
rna
tube
thermo
fisher
scientif
waltham
sampl
frozen
prior
transfer
laboratori
analysi
whole
blood
paxgen
tube
invert
mix
store
shipment
receiv
laboratori
sampl
log
store
deidentifi
human
specimen
test
posit
human
virus
obtain
univers
alabama
birmingham
depart
pediatr
molecular
diagnost
laboratori
specimen
type
includ
swab
skin
whole
blood
plasma
minut
nucleic
acid
extract
method
use
nasal
sampl
blood
specimen
total
nucleic
acid
extract
use
viru
mini
kit
biorobot
procedur
essenti
nasal
specimen
blood
specimen
suspend
buffer
atl
vortex
prior
extract
instrument
overal
goal
studi
assess
specimen
sow
piglet
deriv
cesarean
section
infecti
agent
help
understand
rate
infect
cohort
potenti
transmiss
virus
sow
piglet
initi
object
focus
character
assay
establish
reproduc
sensit
specif
well
establish
lower
limit
detect
help
compar
result
present
laboratori
addit
studi
examin
differ
sampl
type
anim
help
understand
effici
way
detect
infecti
agent
test
final
set
piglet
deriv
cesarean
section
evalu
compar
rate
infect
sow
deriv
adapt
primer
probe
set
report
literatur
common
platform
achiev
increas
decreas
length
oligonucleotid
use
primer
probe
target
overlap
amplifi
region
report
approach
result
assay
similar
perform
characterist
evid
similar
assay
perform
paramet
summar
tabl
initi
studi
assay
agent
list
tabl
establish
llod
evalu
seri
control
dna
known
copi
number
assess
sensit
assay
experiment
result
compar
input
copi
number
use
statist
method
calcul
bestfit
line
assess
linear
sensit
assay
summari
perform
assay
provid
tabl
includ
slope
r
coeffici
standard
deviat
residu
llod
refer
analyt
assay
data
also
summar
figur
illustr
dynam
rang
linear
reproduc
assay
assay
share
similar
perform
characterist
appear
exhibit
featur
good
quantit
assay
salient
featur
assay
follow
highli
reproduc
standard
deviat
valu
averag
log
copi
concentr
plasmid
ii
assay
highli
sensit
iii
yield
data
quantit
slope
rang
r
coeffici
rang
correspond
standard
deviat
residu
valu
iv
assay
prove
quantit
noro
wnv
rota
v
quantit
assay
exhibit
llod
valu
copi
defin
copi
number
could
detect
frequenc
calcul
probit
analysi
confirm
high
level
sensit
second
lower
set
control
plasmid
dilut
prepar
two
three
assay
detect
cognat
sequenc
assay
includ
copi
target
except
lcmv
specimen
detect
copi
data
present
qualit
assay
llod
defin
lowest
concentr
sampl
test
posit
tabl
llod
everi
one
quantit
assay
copi
per
assay
similar
sensit
valid
hsv
assay
use
clinic
specimen
use
document
concentr
control
plasmid
sensit
hsv
assay
also
determin
platform
use
confirm
accuraci
llod
estim
llod
control
assay
nearli
ident
sensit
determin
clinic
laboratori
valid
plasmid
control
solut
provid
assur
assay
platform
perform
design
data
present
final
assay
noro
wnv
rota
highli
sensit
appear
yield
good
quantit
data
indic
low
r
coeffici
aberr
slope
valu
tabl
ongo
effort
laboratori
evalu
new
primer
set
hope
improv
assay
ad
addit
target
expect
assay
exhibit
excel
linear
yield
highqual
quantit
data
figur
tabl
addit
highli
reproduc
appar
error
bar
shown
figur
three
assay
wnv
rota
noro
highli
sensit
yield
low
slope
valu
elev
standard
deviat
residu
valu
indic
assay
would
gener
highqual
quantit
data
thu
consid
qualit
assay
see
figur
tabl
target
detect
analysi
obtain
porcin
cyclophilin
gene
use
detect
host
dna
preanalyt
control
sampl
integr
expect
given
high
level
conserv
pig
human
gene
target
three
nucleotid
base
pair
target
sequenc
differ
porcin
human
gene
also
nucleic
acid
prepar
clinic
laboratori
sampl
spike
influenza
b
viru
consequ
ifb
control
also
neg
expect
notabl
none
assay
porcin
virus
detect
virus
human
specimen
instanc
primer
porcin
herpesvirus
pcmv
amplifi
human
herpesviru
sequenc
specimen
includ
hsv
hcmv
vzv
ebv
even
though
two
specimen
test
contain
copiesml
vzv
hsv
respect
data
confirm
assay
highli
specif
appear
crossreact
mani
infect
might
expect
occur
human
subject
f
g
u
r
e
sensit
linear
qpcr
assay
set
plasmid
contain
target
nucleic
acid
sequenc
subject
set
dilut
yield
absolut
copi
number
shown
horizont
axi
xy
plot
dilut
quantifi
six
separ
experi
averag
copi
number
calcul
shown
vertic
axi
plot
error
bar
repres
standard
deviat
valu
assay
yield
linear
relationship
low
standard
deviat
valu
slope
approach
howev
assay
perform
level
requir
quantit
assay
includ
wnv
noro
rota
panel
e
f
respect
assay
three
virus
prove
highli
sensit
good
qualit
assay
assay
yield
similar
amplif
characterist
differ
specif
amplif
effici
contribut
differ
slope
yintercept
assay
c
c
continu
valid
assay
describ
use
assess
blood
nasal
stool
tissu
specimen
set
adult
anim
piglet
deriv
caesarian
section
data
present
togeth
tabl
overal
studi
perform
well
detect
singl
small
number
specif
target
anim
signal
detect
assay
target
consist
high
specif
assay
describ
specimen
adult
anim
neg
everi
viral
infect
without
regard
pervc
statu
two
anim
neg
viral
mycoplasma
target
infect
influenza
rotaviru
parvoviru
circoviru
observ
expect
herd
vaccin
virus
also
consist
data
suggest
highli
specif
assay
common
target
detect
haemotrop
gener
neg
studi
mycofposit
sampl
stool
nasal
specimen
detect
blood
specimen
anim
result
confirm
assay
two
group
mycoplasma
highli
specif
suggest
differ
group
haemotrop
mycoplasma
speci
distinct
tissu
tropism
unsurpris
mani
anim
infect
mycoplasma
speci
infect
mycoplasma
hyopneumonia
relat
speci
common
infect
pig
gammaherpesvirus
frequent
detect
virus
adult
anim
observ
two
anim
posit
virus
specimen
test
posit
gamma
herpesviru
specimen
posit
indic
assay
specif
distinguish
virus
dna
virus
often
detect
blood
nasal
although
one
stool
specimen
test
posit
anim
also
posit
signal
blood
specimen
result
larg
expect
infect
frequent
detect
feral
domest
hog
mani
geograph
region
assay
describ
detect
coronavirus
phev
tgev
close
relat
viru
porcin
respiratori
coronaviru
prcv
well
porcin
epidem
diarrhea
viru
pedv
specimen
test
anim
describ
obtain
summer
month
none
test
posit
virus
howev
phev
detect
adult
anim
specimen
obtain
winter
respiratori
season
data
present
unexpect
frequent
detect
domest
anim
us
assay
pervc
detect
target
sequenc
adult
anim
posit
specimen
includ
blood
nasal
stool
sampl
two
anim
level
pervc
within
order
magnitud
pcyp
control
might
indic
assay
detect
integr
pervc
sequenc
third
anim
pervc
level
detect
low
order
magnitud
lower
pcyp
control
contrast
result
adult
anim
piglet
deliv
caesarian
section
neg
target
test
except
singl
posit
nasal
specimen
posit
mycoplasma
haemof
group
tabl
result
consist
result
adult
anim
target
detect
often
stool
nasal
specimen
one
notabl
result
three
separ
set
piglet
deriv
sow
detect
yet
none
piglet
appear
infect
viru
one
sow
also
infect
yet
appear
transmit
either
viru
piglet
deliv
caesarian
section
result
confirm
vertic
transmiss
agent
ineffici
confirm
other
also
procedur
use
deriv
piglet
could
also
minim
transmiss
virus
singl
anim
tabl
piglet
yield
posit
result
three
separ
virus
includ
influenza
viru
reoviru
rotaviru
result
trigger
investig
coinfect
three
viral
agent
unusu
specimen
reextract
repeat
target
detect
determin
fals
posit
result
test
pig
specimen
indic
assay
perform
well
typic
detect
small
number
target
nucleic
acid
expect
also
show
piglet
deriv
caesarian
section
typic
neg
target
detect
sow
deriv
data
consist
high
specif
observ
assay
typic
singl
small
number
specif
target
de
overarch
goal
studi
provid
wellcharacter
set
assay
detect
viru
nucleic
acid
help
ensur
microbiolog
safeti
organ
research
purpos
well
monitor
potenti
transmiss
agent
transplant
recipi
list
virus
test
determin
separ
effort
identifi
agent
may
occur
local
geograph
rang
nil
rate
host
rang
extend
human
pig
resid
list
virus
applic
swine
cfr
assay
describ
hold
promis
part
screen
program
identifi
suitabl
donor
anim
valid
releas
transplant
organ
research
purpos
monitor
transplant
recipi
frequenc
test
specif
specimen
test
obvious
vari
depend
specif
need
molecular
assay
remain
test
approach
describ
similar
comprehens
microbiolog
safeti
approach
agaros
encapsul
rabv
reo
reo
reo
rota
sapo
sva
tgev
wnv
analyt
approach
present
continu
use
common
infecti
agent
detect
data
present
speci
haemotrop
mycoplasma
group
adult
anim
test
neg
sampl
type
assay
report
previous
two
major
group
mycoplasma
also
appear
highli
specif
anim
infect
either
one
two
group
mycoplasma
interest
mycoplasma
haemominutum
group
detect
blood
specimen
mycoplasma
haemof
group
detect
nasal
stool
specimen
also
confirm
specif
assay
unsurpris
mani
anim
infect
mycoplasma
speci
infect
mycoplasma
hypopneumonia
relat
speci
common
infect
pig
gammaherpesvirus
frequent
detect
virus
sow
observ
dna
detect
blood
nasal
specimen
includ
one
anim
posit
signal
blood
nasal
specimen
anim
infect
one
anim
posit
blood
nasal
second
posit
blood
third
anim
posit
blood
stool
total
specimen
test
anim
two
posit
virus
suggest
assay
distinguish
virus
also
consist
high
specif
describ
assay
tabl
analyt
approach
describ
evalu
infect
assay
detect
four
coronavirus
import
mani
coronavirus
cross
speci
barrier
readili
caus
zoonot
infect
target
swine
hepat
e
detect
specimen
notwithstand
use
assay
report
highli
sensit
viru
swine
hepat
e
viru
potenti
infect
human
describ
excel
recent
review
go
forward
critic
monitor
sow
particularli
piglet
ensur
transplant
tissu
remain
free
viru
studi
present
limit
avail
pig
specimen
test
posit
laboratori
infecti
agent
describ
also
limit
rel
small
number
anim
describ
detail
report
howev
subsequ
evalu
addit
specimen
result
detect
target
includ
sva
noro
ifa
phev
prr
rota
bvdv
pcmv
padv
mycof
mycom
pervc
pcyp
specimen
spike
emcv
detect
target
pig
specimen
provid
reassur
analyt
method
function
design
priori
reason
target
might
difficult
detect
other
method
describ
importantli
data
data
tabl
also
help
document
analyt
specif
assay
infecti
diseas
panel
porcin
specimen
specimen
evalu
separ
assay
differ
virus
parallel
detect
one
posit
target
typic
occur
togeth
neg
result
remain
target
ideal
assay
valid
process
would
similar
use
assay
human
virus
clinic
use
describ
report
clinic
trial
continu
effort
evalu
larg
number
porcin
specimen
expect
yield
posit
sampl
target
valuabl
reagent
valid
studi
continu
sensit
assay
describ
compar
favor
sensit
describ
similar
assay
describ
other
pcmv
sensit
copyreact
report
similar
copiesreact
report
previous
hev
sensit
copiesreact
report
similar
genom
equivalentsreact
report
previous
sensit
qpcr
assay
use
mani
differ
laboratori
like
similar
adopt
intern
standard
world
health
organ
would
help
make
direct
comparison
possibl
futur
nonetheless
high
sensit
analyt
specif
assay
describ
suggest
perform
least
well
describ
previou
report
discuss
assay
describ
select
design
provid
parallel
evalu
compar
larg
set
target
select
help
minim
risk
diseas
transmiss
xenotransplant
set
assay
larg
autom
possibl
individu
evalu
least
specimen
per
day
panel
assay
could
also
easili
multiplex
addit
differ
fluoresc
label
probe
code
sequenc
primer
flexibl
approach
afford
import
move
forward
inform
potenti
risk
improv
target
ad
set
agent
describ
work
nonetheless
panel
report
herein
promis
provid
data
enhanc
safeti
porcin
tissu
xenotransplant
also
valuabl
evalu
human
specimen
follow
xenotransplant
project
fund
part
fund
uab
depart
pediatr
mnp
nation
institut
health
grant
ajt
part
project
fund
unit
therapeut
joe
tector
hold
patent
field
pig
engin
xenotransplant
also
found
compani
xenobridg
llc
mark
n
prichard
http
